When Taxol met tubulin.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Structural Alerts for Aneuploidy Prediction: Are We There Yet?Toxics · 2026
   Article
2. Mechanisms and Therapeutic Strategies for Minority Cell-Induced Paclitaxel Resistance and Tumor Progression Mediated by Mechanical Forces.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
   Article
3. Plants against cancer: towards green Taxol production through pathway discovery and metabolic engineering.aBIOTECH · 2024
   Review
4. Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models.Nutrients · 2024
   Article
5. Long Noncoding RNAs in Taxane Resistance of Breast Cancer.International journal of molecular sciences · 2023
   Review
6. Analogues of Anticancer Natural Products: Chiral Aspects.International journal of molecular sciences · 2023
   Review
7. The Preventive Effects of Naringin and Naringenin against Paclitaxel-Induced Nephrotoxicity and Cardiotoxicity in Male Wistar Rats.Evidence-based complementary and alternative medicine : eCAM · 2022
   Article
8. Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles.Cancers · 2021
   Review
9. Platinum drugs and taxanes: can we overcome resistance?Cell death discovery · 2021
   Review
10. PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis.Oncology research · 2021
    Article
11. A Compressive Review about TaxolMolecules (Basel, Switzerland) · 2020
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as